Stay updated with breaking news from Cellecta Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The global CRISPR gene editing market is projected to reach $18.85 billion by 2031, reveals the premium market intelligence study by BIS...
/PRNewswire/ -- The global CRISPR gene editing market is projected to reach $18.85 billion by 2031, reveals the premium market intelligence study by BIS...
Published: Jul 01, 2021 CRISPR and Cas Genes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global CRISPR and Cas genes market was valued at US$ 7,234.5 Mn by 2026, expanding at a CAGR of around 20.1% from 2018 to 2026. Increase in applications of CRISPR and Cas gene editing technology in bacteria and usage of gene editing technology for prevention of various diseases are the major factors anticipated to drive the market from 2018 to 2026. Rise in need of alternative medicine for chronic diseases and increase ...
Share this article Share this article ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the global market for CRISPR Technology estimated at US$680.3 Million in the year 2020, is projected to reach a revised size of US$2.7 Billion by 2027, growing at a CAGR of 21.8% over the period 2020-2027. Products, one of the segments analyzed in the report, is projected to record 21.1% CAGR and reach US$1.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjuste...
Share this article Share this article ResearchAndMarkets.com's offering. The global CRISPR gene editing market was valued at $846.2 million in 2019 and is expected to reach $10,825.1 million by 2030, registering a CAGR of 26.86% during the forecast. The development of genome engineering with potential applications proved to reflect a remarkable impact on the future of the healthcare and life science industry. The high efficiency of the CRISPR-Cas9 system has been demonstrated in various studies for genome editing, which resulted in significant investments within the field of genome engineeri...